Staying Healthy
Study shows benefit of high-dose flu vaccine in elders
Image: Thinkstock |
A high-dose version of the flu vaccine protected older people from influenza infection better than the normal-dose version, according to a study in The New England Journal of Medicine. The manufacturer of the high-dose flu shot, called Fluzone, conducted the study.
The study involved 32,000 people 65 and older who were immunized during the 2011–12 and 2012–13 flu seasons. The high-dose version contained four times the amount of vaccine as in a standard shot.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.